Literature DB >> 8241498

Fatal Epstein-Barr virus-associated hemophagocytic syndrome.

H Kikuta1, Y Sakiyama, S Matsumoto, T Oh-Ishi, T Nakano, T Nagashima, T Oka, T Hironaka, K Hirai.   

Abstract

A virus-associated hemophagocytic syndrome is characterized by high fever, liver dysfunction, coagulation abnormalities, pancytopenia, and a benign histiocytic proliferation with prominent hemophagocytosis in bone marrow, lymph node, spleen, and liver. We describe six Japanese children with fatal Epstein-Barr virus (EBV)-associated hemophagocytic syndrome. Five of the six patients had serologic evidence of primary EBV infection at the onset of their diseases. EBV genomes were detected in all the patients by Southern blot hybridization or the polymerase chain reaction. Furthermore, clonality analysis of the EBV genome showed that EBV-infected cells proliferated monoclonally or biclonally in three examined patients. In situ hybridization study using EBV-encoded RNA 1 (EBER1) showed that EBER1 was detected in one of two examined liver tissues, which localized in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241498

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Defining the elusive boundaries of chronic active Epstein-Barr virus infection.

Authors:  Sebastian Fernandez-Pol; Oscar Silva; Yasodha Natkunam
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941

3.  A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases.

Authors:  N Takahashi; A Chubachi; M Kume; Y Hatano; A Komatsuda; Y Kawabata; N Yanagiya; Y Ichikawa; A B Miura; I Miura
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

4.  An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.

Authors:  K Hayashi; N Ohara; N Teramoto; S Onoda; H L Chen; T Oka; E Kondo; T Yoshino; K Takahashi; J Yates; T Akagi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

6.  Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.

Authors:  Jin-Seok Lee; Jin-Han Kang; Geon-Kook Lee; Hyeon-Jin Park
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

7.  Fulminant hemophagocytic syndrome with a high interferon gamma level diagnosed as macrophage activation syndrome.

Authors:  Tsuyoshi Muta; Yujiro Yamano
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

8.  Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.

Authors:  Eric Masy; Eric Adriaenssens; Claire Montpellier; Pascale Crépieux; Alexandra Mougel; Brigitte Quatannens; Gautier Goormachtigh; Nathalie Faumont; Fabienne Meggetto; Claude Auriault; Hervé Groux; Jean Coll
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

Authors:  Dai Iwakiri; Li Zhou; Mrinal Samanta; Misako Matsumoto; Takashi Ebihara; Tsukasa Seya; Shosuke Imai; Mikiya Fujieda; Keisei Kawa; Kenzo Takada
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307

10.  Severe chronic active EBV infection in an adult patient: case report.

Authors:  Sang-Yoon Ha; Chul-Won Chung; Young H Ko
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.